Gopalbhai Kanijibhai Vaghela, MD in Sumter, SC - Medicare Internal Medicine

Gopalbhai Kanijibhai Vaghela, MD is a medicare enrolled "Hospitalist" physician in Sumter, South Carolina. He graduated from medical school in 2006 and has 18 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Prisma Health Medical Group-midlands, Mcleod Regional Medical Center Of The Pee Dee, Inc and his current practice location is 129 N Washington St, Sumter, South Carolina. You can reach out to his office (for appointments etc.) via phone at (803) 774-9680.

Gopalbhai Kanijibhai Vaghela is licensed to practice in South Carolina (license number 33084) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013221589.

Contact Information

	Gopalbhai Kanijibhai Vaghela, MD
	129 N Washington St, Sumter, SC 29150-4949
	(803) 774-9680
	(803) 434-3955

Physician's Profile

Full Name	Gopalbhai Kanijibhai Vaghela
Gender	Male
Speciality	Internal Medicine
Experience	18 Years
Location	129 N Washington St, Sumter, South Carolina
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Gopalbhai Kanijibhai Vaghela graduated from medical school in 2006

NPI Data:

NPI Number: 1013221589
Provider Enumeration Date: 07/27/2010
Last Update Date: 10/02/2023

Medicare PECOS Information:

PECOS PAC ID: 5799966834
Enrollment ID: I20110223000495

Medical Identifiers

Medical identifiers for Gopalbhai Kanijibhai Vaghela such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013221589	NPI	-	NPPES
330840	Medicaid	SC
5916219	Medicaid	SC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	33084 (South Carolina)	Secondary
207R00000X	Internal Medicine	33084 (South Carolina)	Secondary
208M00000X	Hospitalist	33084 (South Carolina)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Prisma Health Tuomey	Sumter, SC	Home health agency
Prisma Heath Tuomey Hospital	Sumter, SC	Hospital
Mcleod Regional Medical Center-pee Dee	Florence, SC	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Prisma Health Medical Group-midlands	5991099707	865
Mcleod Regional Medical Center Of The Pee Dee, Inc	7416851852	218

News Archive

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block samples to Rosetta Genomics' CLIA-certified and CAP-accredited laboratory in Philadelphia for analysis using Rosetta's miRview squamous test. FNA is a less invasive method to obtain tumor cells compared with tumor resections or biopsies.

Debate continues over needle/syringe exchange programs

Matt Fisher, a research assistant at the Center for Strategic & International Studies' Global Health Policy Center, summarizes the ongoing debate in Congress over needle and syringe exchange programs (NSEPs) in this post on the SmartGlobalHealth.org blog.

First generic version of Lovenox receives FDA approval for DVT

The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis, a potentially deadly blood clotting condition.

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

It was also classified as a "Variant of Concern" (VOC B.1.1.7) in December 2020. First discovered in Kent, United Kingdom, in September 2020, this new variant has since been found in more than 29 countries across the globe, including the USA.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Gopalbhai Kanijibhai Vaghela allows following entities to bill medicare on his behalf.

Entity Name	Mcleod Regional Medical Center Of The Pee Dee, Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1154371433 PECOS PAC ID: 7416851852 Enrollment ID: O20031126000251

News Archive

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Debate continues over needle/syringe exchange programs

First generic version of Lovenox receives FDA approval for DVT

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

Entity Name	Prisma Health Medical Group-midlands
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1275988321 PECOS PAC ID: 5991099707 Enrollment ID: O20160802001226

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Debate continues over needle/syringe exchange programs

First generic version of Lovenox receives FDA approval for DVT

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gopalbhai Kanijibhai Vaghela is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Gopalbhai Kanijibhai Vaghela, MD 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603	Gopalbhai Kanijibhai Vaghela, MD 129 N Washington St, Sumter, SC 29150-4949 Ph: (803) 774-9680

News Archive

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Debate continues over needle/syringe exchange programs

First generic version of Lovenox receives FDA approval for DVT

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

Hospitalist Doctors in Sumter, SC

Rima Gandhi, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-9680 Fax: 803-434-3955
Monica S Mccutcheon, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-434-6771
Oliver Pierre Harden, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-774-1788
Praveen Venigalla, Hospitalist Medicare: Medicare Enrolled Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-434-6771 Fax: 803-434-3955
Dr. Suwarat Wongjittraporn, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-771-1788 Fax: 803-774-9113
Guy R Bibeau, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 129 N Washington St, Sumter, SC 29150 Phone: 803-778-5248

Gopalbhai Kanijibhai Vaghela, MD - Medicare Internal Medicine in Sumter, SC

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Debate continues over needle/syringe exchange programs

First generic version of Lovenox receives FDA approval for DVT

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

Medicare Reassignments

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Debate continues over needle/syringe exchange programs

First generic version of Lovenox receives FDA approval for DVT

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Debate continues over needle/syringe exchange programs

First generic version of Lovenox receives FDA approval for DVT

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Debate continues over needle/syringe exchange programs

First generic version of Lovenox receives FDA approval for DVT

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

Hospitalist Doctors in Sumter, SC